
- Pharmaceutical Commerce - January/February 2009
Chapter closes on trial of Georgia distributor of knockoff branded products
Company imported knockoffs from Belize and sold them over the Internet
As reported by MSNBC, Jared Wheat, president of Hi-Tech Pharmaceuticals (Norcross, GA) accepted a plea bargain in federal court for illegally selling the drugs, and will serve a 50-month sentence. The company and other individual defendants will forfeit $3 million in illicit proceeds. However, charges from other alleged actions, including racketeering, and selling diet supplements spiked with ephendrine, were dropped.
Stemming from investigations that concluded with arrests in 2006, Hi-Tech was accused of running a manufacturing facility in Belize from which it imported “generic” versions of Xanax, Valium, Ambien, Zoloft and other branded products. In interviews with MSNBC, West had contended that the products were legal because patent protections for them did not exist in Belize.
Articles in this issue
about 17 years ago
Closing The Circle On Patient Adherenceabout 17 years ago
3PLs Rise in Forward-Thinking Supply Chain Modelsabout 17 years ago
A Pitched Battle in Cardiovascular Drug Marketingabout 17 years ago
Wyeth Loses Supreme Court Case Over 'Implied' Pre-Emptionabout 17 years ago
Syringe Design Gets a Makeoverabout 17 years ago
Refinements in Cold Chain Secondary Packagingabout 17 years ago
Inmar Rebrands Reverse-Logistics and Related Business Unitsabout 17 years ago
The Packaging Contribution to Patient Adherenceabout 17 years ago
Moving the Dial on Patient Adherence



